# Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes

> **NCT02218619** · PHASE2 · COMPLETED · sponsor: **Robin Goland, MD** · enrollment: 20 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Tauroursodeoxycholic Acid (TUDCA)
- **DRUG:** Sugar Pill (placebo)

## Key facts

- **NCT ID:** NCT02218619
- **Lead sponsor:** Robin Goland, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08
- **Primary completion:** 2019-12-31
- **Final completion:** 2019-12-31
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2025-06-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02218619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02218619, "Tauroursodeoxycholic Acid (TUDCA) in New-Onset Type 1 Diabetes". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02218619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*